FDA announces changes to risk strategy requirements for 2 drugs to treat low platelet counts
Links shared publicly online about this topic.
- 0total visits
FDA announces changes to risk strategy requirements for 2 drugs to treat low platelet counts
fda.gov —
Nplate, Promacta, REMS
View full resource at fda.gov
Most Recently Shared on December 6, 2011 at 5:31 pm By:
FDA announces changes to risk strategy requirements for 2 drugs to treat low platelet counts http://t.co/6Jvg4uDv
Advertisement
